The Fill-Finish Manufacturing Market Size was valued at USD 15.4 billion in 2023 and is expected to reach USD 30.68 billion by 2031 and grow at a CAGR of 9% over the forecast period 2024-2031.
Fill and finish is the procedure of filling vials with vaccination and finishing the process of packaging the drug for distribution in the pharmaceutical industry. Many vaccine makers outsource the filling and finishing of their vaccines to third parties. Fill-finish processing follows upstream bio-processing, active agent synthesis by cell culture or fermentation, and downstream purification. This is when the end product has the most value and so has the most to lose if it fails. At this level of development, tried-and-true techniques are most commonly adopted. Risk, expense, and regulatory effort can all be introduced into bio-process operations through innovations.
Get more information on Fill-Finish Manufacturing Market - Request Sample Report
This comprises filling and sealing within final containers, which increasingly include prefilled syringes and other delivery devices, as well as formulation, mixing, or other preparation of active agents into final form, It may consist of liquid or lyophilized powder
KEY DRIVERS:
Increasing technological progress in fill-finish manufacturing processes and Biopharmaceutical industry expansion
Prefilled syringes are becoming more popular for parenteral dose forms.
RESTRAINTS:
The high expenses of isolators and RABS
Increase technological advances in fill-finish manufacturing processes that are tailored to suit market demand.
OPPORTUNITY:
The COVID-19 epidemic has benefited the fill-finish manufacturing industry.
Fill-finish processes are increasingly being outsourced.
CHALLENGES:
The difficulties of preserving sterility in fill-finish manufacturing procedures
Pharmaceutical and biotech businesses, as well as governments worldwide, are collaborating to tackle the COVID-19 outbreak. This is accomplished through assisting in the creation of vaccines in order to meet the challenges of the pharmaceutical supply chain. In addition, there are around 115 vaccine candidates and another 155 compounds in the R&D pipeline. Furthermore, routinely used medications such as hydroxychloroquine have shown a significant increase in demand for COVID-19 control. As many wealthy countries run out of the medicine, there is a spike in demand, which has created enormous prospects for makers of COVID-19 management drugs. As a result of the demand for COVID-19 vaccines and treatment medications, the pharmaceutical and biotechnology industries are expected to increase significantly in the next years.
The market is divided into consumables and instruments based on the product. Prefilled syringes, vials, cartridges, and other consumables such as ampoules, bottles, and IV bags are subdivided further within the consumables segment. The sector of instruments is further subdivided into machines and systems. Machines are further classified into automated, semi-automated, and manual machines. Systems, on the other hand, are further classified as standalone and integrated.
Consumables led the market in 2019 and are predicted to be the fastest-growing sector throughout the forecast period. This segment's substantial share and rapid expansion can be due mostly to rising demand for prefilled syringes, widespread use of vials in lyophilization, and the increasing usage of disposable packaging for pharmaceuticals.
Due to increased outsourcing of fill-finish manufacturing processes from small-sized bio-pharmaceutical enterprises and a growing number of new entrants in the biologics manufacturing market, the contract manufacturing organisations segment is projected to grow over the forecast period.
By Product
Consumables
Prefilled Syringes
Glass PFS
Plastic PFS
Vials
Glass Vials
Plastic Vials
Cartridges
Other consumables (Ampoules, Bottles, IV Bags)
instruments
Systems
Integrated Systems
Standalone Systems
Machine Type
Automated Machines
Semi-automated & Manual Machines
By End User
Pharmaceutical & Biopharmaceutical Companies
Contract Manufacturing Organizations
Other End Users
Europe, North America, Asia Pacific, LATAM, and MEA are the five key regions. Europe had the highest proportion of the worldwide market, followed by North America. Factors such as the emergence of the biosimilar market as a result of the patent expiration of key biologic products, the rising incidence of chronic disorders, and the increased focus of major players on expanding their presence in this region are driving the growth of the European fill-finish manufacturing industry.
During the projected period, the Asia Pacific region is expected to have the greatest CAGR, owing to general growth in the bio-pharmaceutical industry. Factors contributing to the growth of the APAC bio-pharmaceutical market include increased investments by CMOs and important bio-pharmaceutical businesses, increased government backing, advances in R&D infrastructure, and expertise and academic excellence in the APAC region.
Need any customization research on Fill-Finish Manufacturing Market - Enquire Now
REGIONAL COVERAGE:
North America
USA
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Rest of Europe
Asia-Pacific
Japan
south Korea
China
India
Australia
Rest of Asia-Pacific
The Middle East & Africa
Israel
UAE
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
Major Players are West Pharmaceutical Services, Inc., Gerresheimer AG, Maquinaria Industrial Dara, Robert Bosch, Syntegon Technology GmbH, I.M.A., Stevanato Group. (IndustriaMacchineAutomatiche) S.p.A., OPTIMA Packaging Group GmbH, Bausch+Strobel, Groninger& Co. GmbH, Becton, Dickson and Company and other players.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | US$ 15.4 Billion |
| Market Size by 2031 | US$ 30.68 Billion |
| CAGR | CAGR of 9% From 2024 to 2031 |
| Base Year | 2023 |
| Forecast Period |
2024-2031 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (Consumables (Prefilled Syringes (Glass PFS, Plastic PFS), Vials (Glass Vials, Plastic Vials), Cartridges, Other consumables (Ampoules, Bottles, IV Bags)), Instruments (Systems (Integrated Systems, Standalone Systems), Machine Type (Automated Machines, Semi-automated & Manual Machines)) • By End-Use (Pharmaceutical & Biopharmaceutical Companies, Contract Manufacturing Organizations, Other End Users) |
| Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | West Pharmaceutical Services, Inc., Gerresheimer AG, Maquinaria Industrial Dara, Robert Bosch, Syntegon Technology GmbH, I.M.A., Stevanato Group. (IndustriaMacchineAutomatiche) S.p.A., OPTIMA Packaging Group GmbH, Bausch+Strobel, Groninger& Co. GmbH, Becton, Dickson and Company |
| Key Drivers | • Prefilled syringes are becoming more popular for parenteral dose forms. |
| RESTRAINTS | • The high expenses of isolators and RABS • Increase technological advances in fill-finish manufacturing processes that are tailored to suit market demand. |
Ans: The Fill-Finish Manufacturing market is expected to reach USD 30.68 billion by 2031.
Ans: The CAGR of the Fill-Finish Manufacturing Market is 9% Over the forecast period 2024-2031.
Ans: The difficulties of preserving sterility in fill-finish manufacturing procedures
Increasing technological progress in fill-finish manufacturing processes and Biopharmaceutical industry expansion
Prefilled syringes are becoming more popular for parenteral dose forms.
Ans: The Fill-Finish Manufacturing Market is segmented into three types by Instruments, by End User, and by Product.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia War
4.3 Impact of Ongoing Recession
4.3.1 Introduction
4.3.2 Impact on major economies
4.3.2.1 US
4.3.2.2 Canada
4.3.2.3 Germany
4.3.2.4 France
4.3.2.5 United Kingdom
4.3.2.6 China
4.3.2.7 Japan
4.3.2.8 South Korea
4.3.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. fill-finish manufacturing market, By Product
8.1 Consumables
8.1.1 Prefilled Syringes
8.1.1.1 Glass PFS
8.1.1.2 Plastic PFS
8.1.2 Vials
8.1.2.1 Glass Vials
8.1.2.2 Plastic Vials
8.1.3 Cartridges
8.1.4 Other consumables (Ampoules, Bottles, IV Bags)
8.2 Instruments
8.2.1 Systems
8.2.1.1 Integrated Systems
8.2.1.2 Standalone Systems
8.2.2 Machine Type
8.2.2.1 Automated Machines
8.2.2.2 Semi-automated & Manual Machines
9. fill-finish manufacturing market, By End User
9.1 Pharmaceutical & Biopharmaceutical Companies
9.2 Contract Manufacturing Organizations
9.3 Other End Users such as Research & Development Laboratories and Academic Research Institutions
10. Regional Analysis
10.1 Introduction
10.2 North America
10.2.1 USA
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.3.6 The Netherlands
10.3.7 Rest of Europe
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 South Korea
10.4.3 China
10.4.4 India
10.4.5 Australia
10.4.6 Rest of Asia-Pacific
10.5 The Middle East & Africa
10.5.1 Israel
10.5.2 UAE
10.5.3 South Africa
10.5.4 Rest
10.6 Latin America
10.6.1 Brazil
10.6.2 Argentina
10.6.3 Rest of Latin America
11. Company Profiles
11.1 West Pharmaceutical Services, Inc.
11.1.1 Financial
11.1.2 Products/ Services Offered
11.1.3 SWOT Analysis
11.1.4 The SNS view
11.2 Gerresheimer AG
11.3 Maquinaria Industrial Dara
11.4 Robert Bosch
11.5 Syntegon Technology GmbH
11.6 I.M.A. (IndustriaMacchineAutomatiche) S.p.A.
11.7 OPTIMA Packaging Group GmbH
11.8 Bausch+Strobel, Groninger& Co. GmbH
11.9 Becton, Dickson and Company
11.10 Stevanato Group
12. Competitive Landscape
12.1 Competitive Benchmarking
12.2 Market Share Analysis
12.3 Recent Developments
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Dose Calibrator Market Size was valued at USD 1.5 Billion in 2023 and is expected to reach USD 2.1 Billion by 2032 and grow at a CAGR of 3.9% over the forecast period 2024-2032.
The Blockchain Technology in Healthcare Market was valued at USD 7.13 billion in 2023 and is expected to reach USD 595.31 billion by 2032 and grow at a CAGR of 63.5% over the forecast period 2024-2032.
The U.S. Pharmacy Benefit Management Market was valued at USD 432.30 billion in 2023 and is expected to reach USD 947.90 billion by 2032 and grow at a CAGR of 9.13% over the forecast period 2024-2032.
Upstream Bioprocessing Market was valued at USD 22.79 Bn in 2023 and is anticipated to touch USD 82.10 Bn by 2032, growing at a CAGR of 15.35% from 2024-2032.
The Fill-Finish Manufacturing Market Size was valued at USD 15.4 billion in 2023 and is expected to reach USD 30.68 billion by 2031 and grow at a CAGR of 9% over the forecast period 2024-2031.
The Bio Decontamination Market size was estimated at USD 225 million in 2022 and is expected to reach USD 410.3 million by 2030 with a growing CAGR of 7.8% during the forecast period of 2023-2030.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
